Affordable Access

Potential New Cysteine Sparing Mutation in the NOTCH3 Gene in a Patient with Nonfamilial CADASIL-like Disease.

Authors
  • Qureshi, Adnan I1
  • Khan, Muhammad T1
  • Naveed, Omer1
  • Saleem, Muhammad A1, 2
  • 1 Zeenat Qureshi Stroke Institute, St. Cloud, MN, USA.
  • 2 Mercyhealth, Janesville, WI, USA.
Type
Published Article
Journal
Journal of vascular and interventional neurology
Publication Date
Dec 01, 2017
Volume
9
Issue
6
Pages
51–54
Identifiers
PMID: 29445441
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Several different mutations have been reported in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). We present a unique case with transversion not involving cysteine on neurogenic locus notch homolog protein 3 gene. We present a case of 65-year-old woman with new ischemic stroke resulting in right hemiparesis. She has previously suffered minor strokes at age 56, 58, and 60 years and migraine headaches between age 10 and 50 years. Magnetic resonance imaging demonstrated multifocal chronic ischemic infarctions with encephalomalacia in the left posterior parietal, parieto-occipital regions and the pons. An analysis of the protein sequence of notch 3 gene did not demonstrate any alterations characteristics of CADASIL disease. There was a deoxyribonucleic acid variant with transversion of alanine with tyrosine and change of histidine with leucine on notch 3 gene. None of the family members had any clinical manifestations suggestive of CADASIL. We report the first report of deoxyribonucleic acid variation in notch 3 gene associated with clinical features of CADASIL without any familial component.

Report this publication

Statistics

Seen <100 times